The Immuno-oncology workshop, organized by PhD students from the Toulouse Cancer Research Center (CRCT), will take place on Thursday, October 16th, 2025, at the IUCT-Oncopole Amphitheater (1 Avenue Irène Joliot-Curie, 31100 Toulouse).
This event is designed to connect researchers and clinicians around the latest developments in immuno-oncology, bridging computational innovation and clinical application.
Deadline for submission of abstracts: September 26, 2025 (11:59 pm)
Registration and submitting an abstract are two different processes. But for both, you need a sciencesconf account.
If you don't have a sciencesconf account, you can follow this tutorial to create it:
The immune system plays a key role in cancer because it can detect and eliminate tumor cells through multiple biological mechanisms. Over the last decade, deep exploration of immune-tumor interactions has opened the door to immunotherapies that have reshaped cancer care. Despite these advances, challenges remain: not all patients respond to treatment, and resistance can develop. New strategies increasingly rely upon the integration of bioinformatics and computational modeling to address all of these gaps and to better understand tumor-immune dynamics, as well as design personalized interventions for predicting therapeutic outcomes.
This workshop will present diverse perspectives regarding how multidisciplinary research is shaping the next generation of cancer therapies, from laboratory discoveries to computational frameworks and clinical trials.
Invited speakers
Dr. Jasmin Fisher
UCL Cancer Institute, University College London, UK
Cancer Digital Twins
Dr. Sébastien Benzekry
COMPO, Inria and Cancer Research Center of Marseille (Inserm, Aix-Marseille University, Paoli Calmettes Institute)
Mechanistic learning to predict response and survival in immuno-oncology
Dr. Noémie Leblay
Arthur J.E. Child Comprehensive Cancer Center, Arnie Charbonneau Cancer Institute, University of Calgary, Canada
Tolerogenic dendritic cells and immunosuppressive milieu cause resistance to daratumumab and IMiDs in multiple myeloma
Dr. Gaoussou Sanou
IGH – Institut de Génétique Humaine (CNRS, Université de Montpellier)
IMGT/mAb-KG: the IMGT-KG dedicated to monoclonal antibodies
Additional program highlights
The workshop will also feature contributions from PhD students and post-doctoral researchers, offering a comprehensive overview of ongoing immuno-oncology projects in the Toulouse region and beyond.
Contributors & Support
Sponsored by: CARe, SFR-B2S, PROTEIGENE, Novogene GmbH and Fondation Toulouse Cancer Santé
Organizing committee: Benoit Aliaga, Hugo Chenel, Hafida Hamdache, Marcelo Hurtado
Acknowledgements: Pierre Cordelier, Roxana Khazen, Ludovic Martinet, Vera Pancaldi, Bruno Segui
Technical and administrative support: Marion Domingues, Claire Mendoza Berrio, Christa Rachelle Joseph
Special thanks: CARe PhD students, Victoria Bruning, Ambroise Jezequel, Nadine Gheziel, Lisa Gutkowski, Frecia Rodriguez
Loading... 
